The structural requirements for recognition of peptidoglycan (PGN) by PGRP-LC and activation of the Drosophila IMD pathway are not yet clear. In order to examine this question more carefully, the activity of peptidoglycan from different types of bacteria was compared in cell-based and whole animal assays. Drosophila S2* cells, but not adult flies, responded to Lys-type Micrococcus luteus PGN, but with significantly less potency compared to Dap-type Escherichia coli PGN, while intact Lys-type PGN from Staphylococcus aureus was inactive. After treatment with lysostaphin, which digests the cross-bridging peptides, S. aureus PGN weakly stimulated the IMD pathway, similar to M. luteus PGN. Further digestion with mutanolysin, which creates monomeric PGN fragments, abolished the activity of S. aureus PGN. On the other hand, monomeric E. coli PGN, generated by mutanolysin digestion, was still active but required different isoforms of PGRP-LC for recognition. Polymeric PGN required only PGRP-LCx, while monomeric E. coli PGN required both the PGRP-LCa and PGRP-LCx isoforms. These results suggest that the recognition by PGRP-LCx alone requires polymeric PGN, and that polymeric Dap-type PGN is a more potent PGRP-LCx agonist, compared to Lys-type PGN. These results also suggest that the heteromeric PGRP-LCa/LCx receptor complex recognizes monomeric Dap-type, but not Lys-type, PGN.
INTRODUCTION
Insects have a robust innate immune response, which effectively combats many types of invasive microorganisms, but lack an adaptive immune response. 1 One critical aspect of the insect immune response is the rapid production of antimicrobial peptides following infection. 2 Two independent signaling pathways, the Toll and IMD pathways, control the transcriptional induction of antimicrobial peptide genes following infection. The Toll pathway responds to Gram-positive bacterial and fungal pathogens, while the IMD pathway preferentially responds to Gram-negative bacteria. 3, 4 Experiments using PGN isolated from different bacteria suggest that this bacterial cell-wall component is differentially recognized by the Toll or IMD pathways. 5, 6 PGN is composed of long carbohydrate chains with repeating disaccharide units (N-acetyl glucosamine [GluNAc] and N-acetyl muramic acid [MurNAc] ) and a stem peptide attached to each MurNAc residue. 7 The stem-peptide contains both Land D-amino acid with a variable sequence. In particular, the third position of the stem-peptide is highly variable. Gramnegative PGN often contains diaminopimelic acid (Dap) at this position, while many Gram-positive bacteria contain lysine (Lys). It is this difference in the stem-peptide sequence which is thought to account for the preferential activation of the IMD pathway by Gram-negative bacteria and PGN. 5, 6 Stem-peptides can also be cross-linked to neighboring stempeptides. The amount of cross-linking and the structure of the cross-bridge are also highly variable.
Drosophila has 13 PGN recognition protein genes (PGRPs), some of which include multiple splice-isoforms, generating a total of a least 17 PGRP polypeptides. 8, 9 The PGRPs play a crucial role in both the Toll and IMD pathways. 10 PGRP-LC and PGRP-LE are implicated in the IMD pathway, where they are thought to recognize Daptype PGN. [11] [12] [13] [14] [15] PGRP-LC mutant flies fail to induce expression of numerous antimicrobial peptide genes in response to Gram-negative bacterial infection or in response to injection of Dap-type PGN. 5 PGRP-LC mutants are hypersusceptible to some Gram-negative infections (i.e. Erwinia carotorova) but in other cases (i.e. Escherichia coli infection), PGRP-LC and PGRP-LE must both be mutated to generate a hypersusceptible phenotype. 12, 15 The Toll pathway relies on two different PGRPs, PGRP-SA and PGRP-SD. [16] [17] [18] PGRP-SA is thought to utilize another protein, GNBP1, as co-receptor for the recognition of PGN from Micrococcus luteus. 17 Recently, we have reported that recognition of a monomeric form of Gram-negative PGN fragment, known as TCT, requires two PGRP-LC alternativesplice isoforms, PGRP-LCa and PGRP-LCx, to activate the IMD pathway, while polymeric Gram-negative PGN requires only PGRP-LCx. 6 These results suggest that long, polymeric PGN might be sufficient to bind and cluster PGRP-LCx, while recognition and signaling by monomeric TCT requires a heteromeric complex of PGRP-LCx and PGRP-LCa.
Several reports have suggested that Gram-positive bacteria and Lys-type PGN can also activate the IMD pathway, but the potency of these materials relative to E. coli PGN was not carefully examined. Steiner and colleagues showed that Staphylococcus aureus PGN could activate the IMD pathway in cell culture, 19 and Hultmark and colleagues similarly showed that live M. luteus or Lys-type PGN, from M. luteus, activated the IMD pathway. 9, 13 Experiments in vivo are less conclusive: live M. luteus induced diptericin expression, 13 but M. luteus PGN did not similarly activate the IMD pathway. 5 In the current study, the highly responsive S2* cells were used to examine the structural requirements for PGN recognition by the IMD pathway, comparing Lys-type and Dap-type PGNs in either polymeric or monomeric forms. Immune activation in vivo was also examined.
MATERIALS AND METHODS

Reagents
Peptidoglycan from S. aureus, M. luteus, Streptomyces spp. and Bacillus subtilis were purchased from Sigma. E. coli PGN was a gift from Håkan Steiner or purchased from Invivogen. PGN was suspended at 2 mg/ml in PBS and sonicated for 10 min in a sonicating water bath. Prior to each use, it was sonicated again for 1 min. PGN digesting enzymes, mutanolysin and lysostaphin, were purchased from Sigma.
Antibacterial peptide expression in cell culture
Drosophila macrophage-like S2* cells were differentiated with 1 µM 20-hydroxy-ecdysone for 24 h prior to treatment with PGN. Total RNA was isolated using the Trizol reagent (Invitrogen) 5 h after stimulation and expression of antimicrobial peptide genes was analyzed by Northern blotting, as previously described. 6 S2* cells stably integrated with a diptericin-luciferase reporter plasmid (S2*/dpt cells) were also used to assay the induction of diptericin after the stimulation with bacterial PGN preparations, as described previously. 6 
Antibacterial peptide expression in vivo
Micro-injections, into 2-5-day-old y w DD1; cn bw adults, were performed as described previously. 6, 20 384 Kaneko,Golenbock, Silverman Fig. 1 . Soluble S. aureus PGN stimulates diptericin expression in S2* cells. Imd signaling was monitored with a luciferase reporter assay, as described in Materials and Methods. Insoluble S. aureus PGN was treated with lysostaphin at 37°C for 18 h, or was mock digested. Lysostaphin-digested S. aureus PGN was fractionated, by microcentrifugation, into soluble (sup.) and insoluble (ppt.) fractions. All Imd stimulatory activity was found in the soluble fraction. PGN-contaminated E. coli LPS (100 ng/ml) was used as positive control.
RNAi
Procedures for performing RNAi in S2* cells were previously described 21 and the design of dsRNAs for the common region and isoforms specific regions of PGRP-LC were published previously. 6 
Enzymatic digestion of PGN
Enzymatic digestion of PGN, with mutanolysin and/or lysostaphin, were as reported previously. 6, 19 In brief, 7.5 µg (150 U) of mutanolysin and 5 µg (22.4 U) of lysostaphin were used in a digestion volume of 500 µl with 1 mg of PGN for ~24 h. Prior to digestion, all PGN samples were insoluble and formed an opaque suspension. After digestion with either mutanolysin or lysostaphin, the PGN became a clear solution, as assayed by visual inspection or by absorbance spectrometry, with only a small amount of insoluble material remaining. The Imd-stimulating activity of these digested PGNs was found in the soluble fraction following digestions ( Fig. 1) .
RESULTS AND DISCUSSION
The ability of different types of PGN to stimulate the IMD pathway was tested in Drosophila S2* cells stably transfected with a diptericin luciferase reporter. These cells were treated with PGN, titrated over seven orders of magnitude, and luciferase reporter activity was monitored 4 h later. As shown in Figure 2A , insoluble polymeric Gram-negative E. coli PGN potently activates this reporter; concentrations as low as 10 ng/ml induced significant activation of diptericin. On the other hand, PGN from M. luteus, Streptomyces spp., and B. subtilis required at least 1 µg/ml to stimulate the diptericin reporter and did not reach as high a level of induction, compared to E. coli PGN, even at the highest dose (10 µg/ml). S. aureus PGN failed to stimulate the diptericin, even at the highest dose. Similarly, cell wall preparations, Peptidoglycan recognition by the Drosophila Imd pathway 385 
A B
cell wall-teichoic acid, and lipoteichoic acid isolated from S. aureus displayed little or no ability to stimulate the Imd pathway in S2* cells (Fig. 3) . While Streptomyces spp. and B. subtilis are both Gram-positive organisms, their PGN contains a Dap residue at the third position of the stem-peptide, which is more common in Gram-negative bacteria. 7 The meso-Dap residue in B. subtilis is highly amidated, relative to the unmodified residue in E. coli PGN. 22 Streptomyces PGN has an L.L-Dap with monoglycine cross-bridge (as compared to meso-Dap and to direct cross-bridging in Gram-negative bacteria). Any of these differences may account for the reduced activity of these Dap-containing Gram-positive PGNs relative to E. coli PGN. On the other hand, S. aureus and M. luteus both contain an L-lysine at the third position of the stem-peptide. It is not clear why some Lys-type PGN (M. luteus) has IMD stimulatory activity while other Lys-type PGN (S. aureus) has no activity.
Perhaps differences in the stem-peptide sequence, cross-bridge structure or the amount of cross-linking are responsible. M. luteus PGN contains glycine-modified glutamic acid in its stem-peptide, which is not found in S. aureus. S. aureus PGN is highly cross-linked (75%) with a 5-glycine cross-bridge, while M. luteus uses a branched pentapeptide (identical to its stem-peptide) for the cross bridge with 25% cross-linking. 23 These data are consistent with other reports that have shown that Gram-negative, Dap-type and M. luteus, Lystype PGN are both capable of activating the Drosophila IMD pathway in cell culture. 9, 13 The dose response analysis shown in Figure 2A clearly demonstrates that Dap-type PGN is a significantly more potent IMD ligand. The activity of M. luteus PGN in Drosophila cell culture is not consistent with other reports examining the activity of various PGN in vivo. 5 Therefore, we examined the activity of these PGNs in vivo, following injection into adult flies. In this case, the induction of diptericin expression was assayed by Northern blotting.
In these experiments, all Dap-type PGN, from E. coli, Streptomyces or B. subtilis, induced significant diptericin expression ( Fig. 2B) . Again, the E. coli PGN was significantly more potent than either of the two Gram-positive Dap-type PGNs. On the other hand, neither Lys-type PGN, from M. luteus or S. aureus, induced significant diptericin expression. These results are similar to those published by Leulier et al., 5 but are clearly different from the response to M. luteus PGN observed in S2* cells ( Fig. 2A) and mbn-2 cells. 9, 13 Possible causes for this discrepancy include developmental differences between the embryo-derived S2* cells and adults, tissue differences between a hemocyte-derived cell line and fat bodies (where the bulk of the diptericin expression occurs in adults), or this discrepancy could be due to the lack of sensitivity in the whole animal assay where injection alone cause significant diptericin induction (see PBS lane, Fig. 2B ) and could obscure low levels of induction. It is also possible that both Lys-type PGNs are rapidly inactivated by endogenous lysozymes found in the hemolymph (see below).
The ability of M. luteus PGN but not S. aureus PGN to activate the IMD pathway (in S2* cells) was intriguing. One major difference between these two types of PGN is the structure of their cross-bridges and the percentage of cross-linking. S. aureus PGN cross-bridges can be enzymatically digested with the glysyl-glycine endopeptidase lysostaphin (Fig. 4A) . Strikingly, lysostaphin digestion of S. aureus PGN generated a species that activates Drosophila IMD pathway in S2* cells (Fig. 4B ). Note, this digestion of S. aureus PGN does not alter it TLR-2 stimulating activity (data not shown) and the lysostaphin itself does not contain IMD stimulating activity (Fig. 4B) . Lysostaphin-treated S. aureus PGN stimulates Drosophila S2* cells at 1 µg/ml, similar to other Lys-type PGNs such as M. luteus PGN, but was one to two orders of magnitude less potent than E. coli Dap-type PGN (compare to Fig. 2A and Kaneko et al. 6 ). Diptericin expression induced by either lysostaphin-digested S. aureus PGN or M. luteus PGN requires only PGRP-LCx (Fig. 4C, data not shown) . The lysostaphin-treated S. aureus PGN was also notable for its sharp threshold of activity, observed at 1 µg/ml. This suggests a highly co-operative interaction is involved in the recognition of this material, and this co-operativity may be due to the highly repetitive nature of the ligand. These results suggest that cross-bridges between adjacent stem-peptides may interfere with recognition by PGRP-LCx. 386 Kaneko,Golenbock, Silverman Fig. 3 . Lipoteichoic acid (LTA) from S. aureus does not stimulate the Imd pathway. S2* cells were treated with either crude cell wall preparations, purified muropeptide-teichoic acid (muropeptide-TA), or purified lipoteichoic acid (LTA) from S. aureus and Diptericin expression was monitored by Northern blotting, after 5 h. S. aureus cell wall preparation (CW) stimulates S2* cells very weakly, but purified muropeptide-teichoic acid or LTA failed to stimulate the expression of diptericin. All compounds were tested at the concentration of 1 µg/ml. PGN-contaminated E. coli LPS (100 ng/ml) was used as positive control. We previously demonstrated that TCT, a monomeric disaccharide Dap-type tetrapeptide naturally produced by Bordetella pertussis, potently activates the IMD pathway and requires both PGRP-LCa and PGRP-LCx. 6 Mutanolysin-digested E. coli PGN was also able to activate the IMD pathway (Fig. 4C ). 6 Like TCT, mutanolysin-digested E. coli PGN requires both PGRP-LCa and PGRP-LCx, while the polymeric PGN required only PGRP-LCx (Fig. 4C ). (Note, the products of mutanolysin-digested E. coli PGN are very similar to TCT, except a small percentage of cross-linked dimers, and higher, may be present and most products lack the 1,6-anhydro arranged N-acetylmuramic acid found in TCT.) Similarly, amidase (PGRP-SC1B)-digested E. coli PGN requires both PGRP-LCa and PGRP-LCx (Fig. 5 ). On the other hand, mutanolysin digestion of lysostaphintreated S. aureus PGN completely abrogated the IMD stimulatory activity of this material (Fig. 4B) , demonstrating that monomeric Lys-type PGN cannot stimulate the IMD pathway. These results suggest that recognition of monomeric PGN strictly requires Dap-containing stem-peptides and that PGRP-LCa and PGRP-LCx, together, are required for the recognition of these Daptype monomers. On the other hand, PGRP-LCx alone may be capable of recognizing Dap-type, and to a lesser degree, Lys-type PGN, but only when it is polymeric.
Recently, the co-crystal structure of mammalian PGRP-Iα and a monomeric substructure of PGN (muramyl tripeptide, MTP) was published. 24 This study demonstrated that monomeric PGRP-Iα binds MTP in a deep groove, with both the peptide and glycan portions of the ligand contributing to the interaction. The simplest model based on our data suggests that PGRP-LCa and PGRP-LCx, together, form a receptor capable of binding monomeric Dap-type PGN. However, the PGRP-Iα/MTP structure does not lead to an obvious prediction of how a monomeric fragment of PGN would contact two PGRP proteins. Perhaps the binding mechanism of PGRP-LCa/LCx and TCT is significantly different from that of PGRP-Iα and MTP. Alternatively, the binding of monomeric PGN to one subunit, for example PGRP-LCx, could drive the association of the two PGRP-LC isoforms, via a conformational change induced upon the ligand binding. This association would then be sufficient to activate intracellular signal transduction. This model is supported by a recent publication demonstrating that TCT can induce the dimerization of PGRP-LCx and PGRP-LCa. 25 In the case of polymeric PGN, the repetitive nature of the ligand may be sufficient to induce the interaction of multiple PGRP-LCx molecules, and thereby activate signaling. This type of signaling might be similar to antibody-mediated receptor cross-linking, an avidity mechanism. The experiments comparing S. aureus PGN before and after digestion with lysostaphin suggest that highly cross-linked PGN is a less effective agonist for PGRP-LCx, suggesting that these crossbridges interfere with binding to these receptors. Further molecular and structural studies will be necessary to resolve these issues. 
